Sanofi is a global pharma anchored by blockbuster immunology drug Dupixent, refocusing purely on innovative medicines. It trades on Euronext Paris under the ticker SAN, in the Pharmaceuticals sector.
Key Facts
| Item | Details |
|---|---|
| Ticker | SAN |
| Exchange | Euronext Paris (SAN) |
| Sector | Pharmaceuticals |
| Headquarters | Paris, France |
Bull Case & Risks
Bull Case
- Dupixent blockbuster growth
- A pipeline-focused refocusing
- A vaccines franchise
Risks
- Dependence on Dupixent
- Pipeline and patent risk
Outlook
Sanofi is refocusing on innovative drugs around its Dupixent powerhouse, betting its pipeline can broaden growth.
Educational information only, not investment advice. Stocks carry risk including possible loss of principal; past performance does not guarantee future results.